E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Obesity > The Epidemic of Obesity

Tags

  • physicians
  • advantages
  • packaged
  • developing combination
  • developing combination
  • combination products

  • Links

  • Freelancer, Consultant, or Entrepreneur - What's the Difference?
  • Day Trade The Bse Sensex As Well As Indian Stocks & Indices
  • Data Recovery Services- What To Do When Your Hard Drive Fails
  • E-Articles - The Epidemic of Obesity

    One of the most serious problems dieticians have to encounter is that of obesity. According to the American Obesity Association (AOA), s
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ocial structure, general and regional trends, socioeconomic transitions, as well as modernization and urbanization are the primary cause
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    that led to the recent increase in obesity rates. The prevalence of overweight people is reported worldwide, both in developing and dev
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    loped countries. Recent changes in consumption, culture, economic development and lifestyle have increased the problem of obesity, both
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    n children and adults. Thus, it is of vital importance for people all around the globe to understand the risks associated with being obe
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    e and direct their efforts in reducing this alarming trend that is spreading.

    The USA obesity rates have reached epidemic proportions a
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    d the numbers are socking. As recent statistical data indicate, 58 million people are overweight, 40 million obese and 3 million morbidl
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    y obese. These numbers are further supported by the fact that 8 out of 10 people over 25 years of age are overweight. Moreover, 78 perce
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    t of Americans do not meet the basic activity level recommendations. Even more alarming are the results that indicate a 76 percent incre
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    se since 1990 in Type II diabetes in adults belonging to the 30 to 40 age group.

    Consequently, a variety of diseases and health problem
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    appear to be directly related to the obesity trend monitored. As the scientific reports land on the physicians' desks, it is reported t
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    at 80 percent of Type II diabetes has to do with the increased levels of obesity in adults, 70 percent of cardiovascular disease is caus
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    d by poor eating habits, 42 percent of breast and colon cancers diagnosed belongs to obese individuals, 26 percent of high blood pressur
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    is caused by the excess weight a person carries and 30 percent of gall bladder surgery is performed on a person that suffers from serio
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    us obesity problems. Moreover, obesity is also a risk factor in higher rates of certain types of cancer as well as fatty liver disease,
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ascular disorders, thrombosis, obstructive sleep apnea, musculoskeletal problems and gastro-esophageal reflux. Abdominal obesity is part
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    cularly associated with insulin resistance syndrome and cardiovascular disease.

    If the numbers above have alarmed you enough to go and
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    eigh out yourself, try to remember that suffering from obesity should not be something you should be ashamed of. You need support and gu
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    dance to change your eating and exercise habits, but most importantly you need to maintain your motivation. Eating smaller quantities is
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    not enough. You have to eat right and keep yourself alert of the severe consequences related with poor nutrition and low exercise levels


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/261734/e-article-The-Epidemic-of-Obesity.html">The Epidemic of Obesity</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/261734/e-article-The-Epidemic-of-Obesity.html]The Epidemic of Obesity[/url]

    Related Articles:

    Australian Franchise Law Affecting Economy

    Tips for Revising Private Label Articles for Healthcare and Self-Help Promotions

    Online Dating - 5 Essential Safety Tips

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com